Welcome to LookChem.com Sign In|Join Free

CAS

  • or

626242-04-4

Post Buying Request

626242-04-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

626242-04-4 Usage

Structure

An imidazole derivative that is an ester of 1-(phenylmethyl)-1H-imidazole-5-methanol and acetic acid

Potential Applications

Pharmaceutical, particularly in medicinal chemistry

Usage

Synthesis of various pharmaceutical drugs, building block for creating new chemical entities with biological activity

Properties

Presence of an imidazole ring, indicating potential biological and pharmacological properties

Value

Valuable in drug development and research due to its potential for biological activity and pharmacological properties.

Check Digit Verification of cas no

The CAS Registry Mumber 626242-04-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,6,2,4 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 626242-04:
(8*6)+(7*2)+(6*6)+(5*2)+(4*4)+(3*2)+(2*0)+(1*4)=134
134 % 10 = 4
So 626242-04-4 is a valid CAS Registry Number.

626242-04-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (1-benzyl-1H-5-imidazolyl)methyl acetate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:626242-04-4 SDS

626242-04-4Relevant articles and documents

Novel N-(4-piperidinyl)benzamide antimalarials with mammalian protein farnesyltransferase inhibitory activity

Ryckebusch, Adina,Gilleron, Pauline,Millet, Regis,Houssin, Raymond,Lemoine, Amelie,Pommery, Nicole,Grellier, Philippe,Sergheraert, Christian,Henichart, Jean-Pierre

, p. 1324 - 1326 (2007/10/03)

Protein farnesyltransferase of Plasmodium falciparum is a potential target in the treatment of malaria for which increased drug resistance is observed. The design, synthesis and evaluation of a series of N-(4-piperidinyl)benzamides is reported. The most potent compounds showed in vitro activity against the parasite at submicromolar concentrations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 626242-04-4